XML 31 R20.htm IDEA: XBRL DOCUMENT v3.5.0.2
Stock Options and Restricted Shares (Tables)
6 Months Ended
Sep. 30, 2016
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Stock-based compensation
The following amounts of stock-based compensation were recorded (in thousands):
 
Three Months Ended September 30,
 
Six Months Ended September 30,
 
2016
 
2015
 
2016
 
2015
Cost of product revenue
$
9

 
$
10

 
$
23

 
$
20

General and administrative
485

 
294

 
752

 
576

Sales and marketing
21

 
57

 
52

 
136

Research and development
24

 
(8
)
 
41

 
6

Total
$
539

 
$
353

 
$
868

 
$
738

Summary of share based payment awards
The following table summarizes information with respect to the Plans:
 
 
 
Outstanding Awards
 
Shares
Available for
Grant
 
Number
of Shares
 
Weighted
Average
Exercise
Price
 
Weighted
Average
Remaining
Contractual
Term (in years)
 
Aggregate
Intrinsic
Value
Balance at March 31, 2016
787,686

 
2,017,046

 
$
3.32

 
4.54
 
 
Shares reserved under new plan
1,750,000

 

 
 
 
 
 
 
Granted stock options

 

 

 
 
 
 
Granted shares
(39,293
)
 

 

 
 
 
 
Restricted shares
(1,047,142
)
 

 

 
 
 
 
Forfeited restricted shares
87,500

 

 

 
 
 
 
Forfeited stock options
74,600

 
(74,600
)
 
4.85

 
 
 
 
Exercised

 

 

 
 
 
 
Balance at September 30, 2016
1,613,351

 
1,942,446

 
$
3.26

 
3.49
 
$
0.00

Exercisable at September 30, 2016
 
 
1,782,846

 
$
3.34

 
3.43
 
$
0.00

Summary of outstanding non-vested stock options
A summary of the status of Orion’s outstanding non-vested stock options as of September 30, 2016 was as follows:
Non-vested at March 31, 2016
205,900

Granted

Vested
(44,300
)
Forfeited
(2,000
)
Non-vested at September 30, 2016
159,600

Summary of restricted shares granted
During the first half of fiscal 2017, Orion granted restricted shares as follows (which are included in the above stock plan activity tables):
Balance at March 31, 2016
1,053,389

Shares issued
1,047,142

Shares vested
(289,111
)
Shares forfeited
(87,500
)
Shares outstanding at September 30, 2016
1,723,920

Per share price on grant date
$1.34 - $6.80